Trial Profile
A Randomized Intervention, Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Arachidonic acid (Primary) ; Docosahexaenoic acid (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 17 Dec 2019 Status changed from recruiting to completed.
- 31 Oct 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 31 Oct 2018 Planned primary completion date changed from 1 May 2018 to 15 Nov 2019.